What additional benefit does radiation offer for a patient <65 years old with T1aN0 ER+ invasive carcinoma (tubular histology) of the breast?

Most of these have low genomic scores and are part of the DEBRA trial and up until that, based on available evidence, would favor adjuvant RT (APBI preferred).